Reena S Cecchini

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Ejection Fraction

Psychometric Properties

Top Venues

NPJ breast cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer prevention research (Philadelphia, Pa.)

This page only lists publications with an associated author ORCID identifier.

Publications

Vinicius Fernando Calsavara, Norah L Henry, Ron D Hays, Sungjin Kim, Michael Luu, Marcio Augusto Diniz, Gillian Gresham, Reena S Cecchini, Greg Yothers, Patricia A Ganz, André Rogatko, Mourad Tighiouart
Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial. Cancer prevention research (Philadelphia, Pa.) (2023)
Norah L Henry, Sungjin Kim, Ron D Hays, Marcio A Diniz, Mourad Tighiouart, Gillian Gresham, Michael Luu, Reena S Cecchini, Greg Yothers, André Rogatko, Patricia A Ganz
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30. NPJ breast cancer 8 (1) (2022)
Patricia A Ganz, Reena S Cecchini, Louis Fehrenbacher, Charles E Geyer, Priya Rastogi, John P Crown, Michael P Thirlwell, David M Ellison, Jean-Francois Boileau, Patrick J Flynn, Jong-Hyeon Jeong, Eleftherios P Mamounas, Norman Wolmark
NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab. NPJ breast cancer 7 (1) (2021)
Norah L Henry, Sungjin Kim, Ron D Hays, Marcio Augusto Diniz, Michael Luu, Reena S Cecchini, Greg Yothers, André Rogatko, Patricia A Ganz
Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (34) (2021)